Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹903 Cr₹1,290 Cr₹582 Cr₹484 Cr₹811 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹903 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹903 Cr
Mar2025₹1,290 Cr
Mar2024₹582 Cr
Mar2023₹484 Cr
Mar2022₹811 Cr

How is Cash Flow from Operating Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹903 Cr
-29.97
Mar2025 ₹1,290 Cr
121.63
Mar2024 ₹582 Cr
20.20
Mar2023 ₹484 Cr
-40.27
Mar2022 ₹811 Cr -

Compare Cash Flow from Operating Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,921.8 Cr 7% 6.7% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹113,589.0 Cr 0.4% 7.9% -6.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

7%

6.7%

-4.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses